Literature DB >> 17437108

Regional CBF changes in Parkinson's disease: a correlation with motor dysfunction.

Jung-Lung Hsu1, Tzyy-Ping Jung, Chien-Yeh Hsu, Wei-Chih Hsu, Yen-Kung Chen, Jeng-Ren Duann, Han-Cheng Wang, Scott Makeig.   

Abstract

PURPOSE: The purpose of this study was to further localize cerebral perfusion abnormalities, and to better correlate these abnormalities with the clinical severity of Parkinson's disease (PD).
METHODS: A single-photon emission computed tomography (SPECT) study was performed on 27 patients with PD and 24 age-matched controls. SPECT images were spatially normalized, concatenated, and then decomposed using Infomax independent component analysis (ICA). The resulting image components were separated by logistic regression into two subspaces: "disease-related" components whose subject weights differed between groups, and "disease-unrelated" components. The resultant regional cerebral blood flow (rCBF) subspace images were normalized to global CBF for each subject, and then processed using statistical parametric mapping to compare rCBF values between PD and control subjects.
RESULTS: In the disease-related image subspace, patients with PD exhibited significantly higher adjusted rCBF in the putamen, globus pallidum, thalamus, brainstem, and the anterior lobe of the cerebellum, and significant hypoperfusion in the parieto-temporo-occipital cortex, the dorsolateral prefrontal cortex, the insula, and the cingulate gyrus. The motor Unified Parkinson's Disease Rating Scale scores correlated negatively with rCBF in the insula and cingulate gyrus. In the disease-unrelated image subspace, no brain voxels exhibited a significant group difference.
CONCLUSION: ICA-based separation of normalized images into disease-related and disease-unrelated subspaces revealed many disease-related group blood flow differences. The regions revealed by ICA are consistent with the current model of PD. These rCBF changes in PD have not been fully demonstrated in any single functional imaging study previously.

Entities:  

Mesh:

Year:  2007        PMID: 17437108     DOI: 10.1007/s00259-006-0360-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  38 in total

1.  Research diagnostic criteria for Parkinson's disease.

Authors:  C D Ward; W R Gibb
Journal:  Adv Neurol       Date:  1990

2.  Analysis of fMRI data by blind separation into independent spatial components.

Authors:  M J McKeown; S Makeig; G G Brown; T P Jung; S S Kindermann; A J Bell; T J Sejnowski
Journal:  Hum Brain Mapp       Date:  1998       Impact factor: 5.038

3.  [99mTc]-HM-PAO SPECT in Parkinson's disease.

Authors:  G Pizzolato; M Dam; N Borsato; B Saitta; C Da Col; N Perlotto; P Zanco; G Ferlin; L Battistin
Journal:  J Cereb Blood Flow Metab       Date:  1988-12       Impact factor: 6.200

4.  Regional blood flow in hemiparkinsonism.

Authors:  J S Perlmutter; M E Raichle
Journal:  Neurology       Date:  1985-08       Impact factor: 9.910

5.  Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.

Authors:  G Berding; P Odin; D J Brooks; G Nikkhah; C Matthies; T Peschel; M Shing; H Kolbe; J van Den Hoff; H Fricke; R Dengler; M Samii; W H Knapp
Journal:  Mov Disord       Date:  2001-11       Impact factor: 10.338

6.  An information-maximization approach to blind separation and blind deconvolution.

Authors:  A J Bell; T J Sejnowski
Journal:  Neural Comput       Date:  1995-11       Impact factor: 2.026

7.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

8.  Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.

Authors:  Atsuko Nagano-Saito; Takashi Kato; Yutaka Arahata; Yukihiko Washimi; Akinori Nakamura; Yuji Abe; Takako Yamada; Katsushige Iwai; Kentaro Hatano; Yasuhiro Kawasumi; Teruhiko Kachi; Alain Dagher; Kengo Ito
Journal:  Neuroimage       Date:  2004-06       Impact factor: 6.556

Review 9.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

10.  Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.

Authors:  A Antonini; P Vontobel; M Psylla; I Günther; P R Maguire; J Missimer; K L Leenders
Journal:  Arch Neurol       Date:  1995-12
View more
  14 in total

1.  Regional CBF changes in Parkinson's disease: the importance of functional neuroimaging analyses.

Authors:  Bárbara J Amorim; Erica C S Camargo; Elba C S C Etchebehere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09       Impact factor: 9.236

2.  Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.

Authors:  Tracy R Melzer; Richard Watts; Michael R MacAskill; John F Pearson; Sina Rüeger; Toni L Pitcher; Leslie Livingston; Charlotte Graham; Ross Keenan; Ajit Shankaranarayanan; David C Alsop; John C Dalrymple-Alford; Tim J Anderson
Journal:  Brain       Date:  2011-02-09       Impact factor: 13.501

Review 3.  Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease.

Authors:  Shichun Peng; David Eidelberg; Yilong Ma
Journal:  Neurosci Bull       Date:  2014-09-28       Impact factor: 5.203

4.  Effects on resting cerebral blood flow and functional connectivity induced by metoclopramide: a perfusion MRI study in healthy volunteers.

Authors:  María A Fernández-Seara; Maite Aznárez-Sanado; Elisa Mengual; Jaione Irigoyen; Franz Heukamp; María A Pastor
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

5.  Deficient supplementary motor area at rest: Neural basis of limb kinetic deficits in Parkinson's disease.

Authors:  Stefanie Kübel; Katharina Stegmayer; Tim Vanbellingen; Sebastian Walther; Stephan Bohlhalter
Journal:  Hum Brain Mapp       Date:  2018-05-02       Impact factor: 5.038

6.  Characterization of disease-related covariance topographies with SSMPCA toolbox: effects of spatial normalization and PET scanners.

Authors:  Shichun Peng; Yilong Ma; Phoebe G Spetsieris; Paul Mattis; Andrew Feigin; Vijay Dhawan; David Eidelberg
Journal:  Hum Brain Mapp       Date:  2013-05-14       Impact factor: 5.038

7.  Functional connectivity of cortical motor areas in the resting state in Parkinson's disease.

Authors:  Tao Wu; Xiangyu Long; Liang Wang; Mark Hallett; Yufeng Zang; Kuncheng Li; Piu Chan
Journal:  Hum Brain Mapp       Date:  2010-08-25       Impact factor: 5.038

8.  Comparison of smooth pursuit eye movement deficits in multiple system atrophy and Parkinson's disease.

Authors:  Elmar H Pinkhardt; Jan Kassubek; Sigurd Süssmuth; Albert C Ludolph; Wolfgang Becker; Reinhart Jürgens
Journal:  J Neurol       Date:  2009-04-12       Impact factor: 4.849

9.  Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson's disease discerned with microSPECT and quantitative MRI.

Authors:  Nadja Van Camp; Ruth Vreys; Koen Van Laere; Erwin Lauwers; Dirk Beque; Marleen Verhoye; Cindy Casteels; Alfons Verbruggen; Zeger Debyser; Luc Mortelmans; Jan Sijbers; Johan Nuyts; Veerle Baekelandt; Annemie Van der Linden
Journal:  MAGMA       Date:  2010-02-19       Impact factor: 2.310

Review 10.  Cerebrovascular plasticity: Processes that lead to changes in the architecture of brain microvessels.

Authors:  Max I Bogorad; Jackson G DeStefano; Raleigh M Linville; Andrew D Wong; Peter C Searson
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-17       Impact factor: 6.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.